Article du mois d’Octobre

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei, L. Paz‑Ares, L. Horn, D.R. Spigel, M. Steins, N.E. Ready, L.Q. Chow,
E.E. Vokes, E. Felip, E. Holgado, F. Barlesi, M. Kohlhäufl, O. Arrieta, M.A. Burgio,
J. Fayette, H. Lena, E. Poddubskaya, D.E. Gerber, S.N. Gettinger, C.M. Rudin,
N. Rizvi, L. Crinò, G.R. Blumenschein, Jr., S.J. Antonia, C. Dorange,
C.T. Harbison, F. Graf
Finckenstein, and J.R. Brahmer
New England Journal of Medicine (Impact Factor: 55.87). 09/2015

nejmoa1507643_Page_01